DE3687501D1 - Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus. - Google Patents
Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.Info
- Publication number
- DE3687501D1 DE3687501D1 DE8686307529T DE3687501T DE3687501D1 DE 3687501 D1 DE3687501 D1 DE 3687501D1 DE 8686307529 T DE8686307529 T DE 8686307529T DE 3687501 T DE3687501 T DE 3687501T DE 3687501 D1 DE3687501 D1 DE 3687501D1
- Authority
- DE
- Germany
- Prior art keywords
- gamma
- diabetes mellitus
- producing
- related compounds
- complications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858524275A GB8524275D0 (en) | 1985-10-02 | 1985-10-02 | Pharmaceutical & dietary compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3687501D1 true DE3687501D1 (de) | 1993-02-25 |
DE3687501T2 DE3687501T2 (de) | 1993-05-19 |
Family
ID=10586062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686307529T Expired - Fee Related DE3687501T2 (de) | 1985-10-02 | 1986-10-01 | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4826877A (de) |
EP (1) | EP0218460B1 (de) |
JP (1) | JPS6296421A (de) |
AT (1) | ATE84414T1 (de) |
AU (1) | AU586286B2 (de) |
CA (1) | CA1279824C (de) |
DE (1) | DE3687501T2 (de) |
ES (1) | ES2043601T3 (de) |
GB (1) | GB8524275D0 (de) |
GR (1) | GR3007043T3 (de) |
HK (1) | HK129393A (de) |
IE (1) | IE59445B1 (de) |
SG (1) | SG115193G (de) |
ZA (1) | ZA867386B (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2197199B (en) * | 1986-11-13 | 1991-04-03 | Efamed | Medicament for treatment of pregnancy-induced hypertension. |
GB8710780D0 (en) * | 1987-05-07 | 1987-06-10 | Scras | Opthalmological application of eicosapentaenoic acid |
US5225441A (en) * | 1987-06-18 | 1993-07-06 | Block Drug Company, Inc. | Treatment of periodontal disease |
JP2524217B2 (ja) * | 1988-04-18 | 1996-08-14 | マルハ株式会社 | 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤 |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
US6140304A (en) * | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
AU620929B2 (en) * | 1988-10-27 | 1992-02-27 | Bar-Ilan University | Method and compositions for treating alzheimer's disease, related dementias and epilepsy |
GB8916734D0 (en) * | 1989-07-21 | 1989-09-06 | Efamol Holdings | Pharmaceutical and dietary uses of fatty acids |
US5407957A (en) * | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
NZ241359A (en) * | 1991-01-24 | 1994-08-26 | Martek Corp | Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils |
GB9111900D0 (en) * | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
JPH0649479A (ja) * | 1992-07-28 | 1994-02-22 | Maruha Corp | ω−3不飽和脂肪酸系化合物の安定化法 |
EP2140863A1 (de) * | 1993-06-09 | 2010-01-06 | Martek Biosciences Corporation | Verwendung von Docosahexaensäure zur Herstellung eines Arzneimittels zur Behandlung von neurologischen Störungen |
US20050027004A1 (en) * | 1993-06-09 | 2005-02-03 | Martek Biosciences Corporation | Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions |
IT1265340B1 (it) * | 1993-07-14 | 1996-11-22 | Istituto Biochimico Italiano | Sostanze inibenti l'adp-ribosilazione proteica atte alla prevenzione delle complicanze del diabete mellito. |
WO1995017889A1 (fr) * | 1993-12-29 | 1995-07-06 | Kowa Tekuno Sachi Co., Ltd. | Composition therapeutique utile pour traiter l'hyperparathyroidie d'un patient en dialyse artificielle |
JPH07143862A (ja) * | 1994-05-06 | 1995-06-06 | Maruha Corp | 脳機能改善効果を有する機能性食品。 |
AU711482B2 (en) * | 1994-06-28 | 1999-10-14 | Scotia Holdings Plc | Compositions for treatment of diabetic complications |
US5968809A (en) * | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
GB9715444D0 (en) * | 1997-07-22 | 1997-09-24 | Scotia Holdings Plc | Therapeutic and dietary compositions |
IL125731A (en) | 1998-08-11 | 2004-06-20 | Zvi Yehuda | Acylates which are products of neurotransmitters and essential fatty acids, pharmaceutical compositions containing them, use of such acylates in the manufacture of medicaments, and method for treating nervous diseases in non-human animals |
US20030163845A1 (en) * | 1998-09-02 | 2003-08-28 | Pradip Mukerji | Elongase genes and uses thereof |
US6677145B2 (en) | 1998-09-02 | 2004-01-13 | Abbott Laboratories | Elongase genes and uses thereof |
DE19903095C2 (de) * | 1999-01-27 | 2003-05-22 | Nutrinova Gmbh | Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium |
US6440931B1 (en) * | 1999-02-23 | 2002-08-27 | Natural Corporation | Conjugated linoleic acid in treatment and prophylaxis of diabetes |
US7070970B2 (en) | 1999-08-23 | 2006-07-04 | Abbott Laboratories | Elongase genes and uses thereof |
AU784123B2 (en) * | 1999-10-13 | 2006-02-09 | Marco A. Chacon | Therapeutic intervention to mimic the effect of caloric restriction |
CA2301158A1 (en) * | 2000-03-24 | 2001-09-24 | Stephen J. Allen | Screening methods for compounds useful for modulating lipid metabolism in disease |
EP1197550A3 (de) * | 2000-08-25 | 2002-11-20 | Pfizer Products Inc. | Methoden und Zusammensetzungen zur Diagnose unde Behandlung von Krankheiten an denen Angiogenese beteiligt ist |
US6635451B2 (en) * | 2001-01-25 | 2003-10-21 | Abbott Laboratories | Desaturase genes and uses thereof |
US7045683B2 (en) * | 2001-05-04 | 2006-05-16 | Abbott Laboratories | Δ4-desaturase genes and uses thereof |
GB0111282D0 (en) * | 2001-05-09 | 2001-06-27 | Laxdale Ltd | Potentiation of therapeutic effects of fatty acids |
PL364093A1 (en) * | 2001-05-30 | 2004-12-13 | Laxdale Limited | Coenzyme q (ubiquinone) and eicosapentaenoic acid (epa) |
US7211656B2 (en) * | 2002-01-30 | 2007-05-01 | Abbott Laboratories | Desaturase genes, enzymes encoded thereby, and uses thereof |
CA2883729C (en) | 2002-05-22 | 2017-03-07 | Virginia M. Ursin | Fatty acid desaturases from fungi |
US7125672B2 (en) * | 2003-05-07 | 2006-10-24 | E. I. Du Pont De Nemours And Company | Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
US7238482B2 (en) * | 2003-05-07 | 2007-07-03 | E. I. Du Pont De Nemours And Company | Production of polyunsaturated fatty acids in oleaginous yeasts |
US7214491B2 (en) * | 2003-05-07 | 2007-05-08 | E. I. Du Pont De Nemours And Company | Δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
GB2422373B (en) * | 2003-08-18 | 2008-05-21 | Btg Int Ltd | Treatment of neurodegenerative conditions |
FR2860720A1 (fr) * | 2003-10-09 | 2005-04-15 | Jean Pascal Conduzorgues | Nouvelles compositions pharmaceutiques pour traiter la xerostomie et maladies similaires |
CN101128475B (zh) | 2003-11-12 | 2012-06-20 | 纳幕尔杜邦公司 | 适用于改变产油植物及酵母中多不饱和脂肪酸水平的△15脂肪酸去饱和酶 |
JP2007533310A (ja) | 2004-04-16 | 2007-11-22 | モンサント テクノロジー エルエルシー | トウモロコシにおける脂肪酸デサチュラーゼの発現 |
US20070265341A1 (en) * | 2004-07-01 | 2007-11-15 | The Schepens Eye Research Institute Inc. | Compositions and methods for treating eye disorders and conditions |
MX2007000208A (es) * | 2004-07-01 | 2007-08-07 | Schepens Eye Res Inst | Composiciones y metodos para tratar trastornos y condiciones del ojo. |
DE102004034640A1 (de) | 2004-07-16 | 2006-02-16 | Institut für Molekular- und Systemmedizin | Verfahren zur systemischen Biokorrektur eines Organismus |
US7138391B2 (en) * | 2004-08-09 | 2006-11-21 | Silverbrook Research Pty Ltd | Hydrophilizable and hydrophilic cyanine dyes |
US7456270B2 (en) * | 2004-09-01 | 2008-11-25 | Abbott Laboratories | Δ6-desaturase genes and uses thereof |
GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
PL1967198T3 (pl) * | 2007-03-07 | 2009-10-30 | Indena Spa | Preparaty zawierające wyciągi z cynara scolymus i phaseolus vulgaris, które są użyteczne w leczeniu otyłości |
EP2358869B1 (de) | 2008-10-06 | 2014-03-26 | Abbott Laboratories | Delta-8-desaturasegene, von diesen kodierte enzyme und ihre verwendung |
CA2743434C (en) * | 2008-11-14 | 2015-04-21 | Bomi P. Framroze | A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis |
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
US8188335B2 (en) | 2009-07-17 | 2012-05-29 | Abbott Laboratories | Δ9-elongase for production of polyunsaturated fatty acid-enriched oils |
US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
EP3151825B1 (de) | 2014-06-04 | 2020-03-25 | DS Biopharma Limited | Pharmazeutische zusammensetzungen enthaltend dgla und verwendung derselben |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058594A (en) * | 1974-04-25 | 1977-11-15 | John Williams | Immuno-suppressive agents |
GB1580444A (en) * | 1976-11-04 | 1980-12-03 | Bio Oil Res | Pharmaceutical compositions |
IE47777B1 (en) * | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
DE3261761D1 (en) * | 1981-07-14 | 1985-02-14 | Efamol Ltd | Pharmaceutical and dietary composition when used for enhancement of 1-series pg production |
DE3366506D1 (en) * | 1982-03-01 | 1986-11-06 | Efamol Ltd | Pharmaceutical composition |
ATE24266T1 (de) * | 1982-04-16 | 1987-01-15 | Nestle Sa | Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung. |
US4472432A (en) * | 1982-05-12 | 1984-09-18 | Inabata & Co., Ltd. | Medicinal use of α,β-unsaturated fatty acids |
AU1933383A (en) * | 1982-09-22 | 1984-03-29 | Sentrachem Limited | Composition of prostaglandins for prevention of cancer |
GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
GB8326130D0 (en) * | 1983-09-29 | 1983-11-02 | Efamol Ltd | Topical preparations containing tars and fatty acids |
FR2558154B1 (fr) * | 1984-01-16 | 1986-08-29 | Pf Medicament | Acides gras ramifies en c10 a c20 utiles en tant que medicaments, et leur procede de preparation |
-
1985
- 1985-10-02 GB GB858524275A patent/GB8524275D0/en active Pending
-
1986
- 1986-09-25 IE IE254386A patent/IE59445B1/en not_active IP Right Cessation
- 1986-09-26 US US06/911,794 patent/US4826877A/en not_active Expired - Fee Related
- 1986-09-29 ZA ZA867386A patent/ZA867386B/xx unknown
- 1986-09-30 AU AU63407/86A patent/AU586286B2/en not_active Ceased
- 1986-10-01 CA CA000519573A patent/CA1279824C/en not_active Expired - Fee Related
- 1986-10-01 EP EP86307529A patent/EP0218460B1/de not_active Expired - Lifetime
- 1986-10-01 ES ES86307529T patent/ES2043601T3/es not_active Expired - Lifetime
- 1986-10-01 AT AT86307529T patent/ATE84414T1/de not_active IP Right Cessation
- 1986-10-01 DE DE8686307529T patent/DE3687501T2/de not_active Expired - Fee Related
- 1986-10-02 JP JP61233373A patent/JPS6296421A/ja active Pending
-
1993
- 1993-02-11 GR GR930400275T patent/GR3007043T3/el unknown
- 1993-10-18 SG SG115193A patent/SG115193G/en unknown
- 1993-11-25 HK HK1293/93A patent/HK129393A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE84414T1 (de) | 1993-01-15 |
HK129393A (en) | 1993-12-03 |
AU586286B2 (en) | 1989-07-06 |
AU6340786A (en) | 1987-04-09 |
IE59445B1 (en) | 1994-02-23 |
EP0218460A3 (en) | 1989-08-09 |
IE862543L (en) | 1987-04-02 |
SG115193G (en) | 1994-01-21 |
GB8524275D0 (en) | 1985-11-06 |
GR3007043T3 (de) | 1993-07-30 |
US4826877A (en) | 1989-05-02 |
ZA867386B (en) | 1987-10-28 |
DE3687501T2 (de) | 1993-05-19 |
EP0218460A2 (de) | 1987-04-15 |
CA1279824C (en) | 1991-02-05 |
JPS6296421A (ja) | 1987-05-02 |
ES2043601T3 (es) | 1994-01-01 |
EP0218460B1 (de) | 1993-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3687501D1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus. | |
ATE73657T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
ATE152910T1 (de) | Verwendung von taxol zur herstellung eines arzneimittels zur behandlung von krebs | |
ATE126433T1 (de) | Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen. | |
AU2118488A (en) | Improvements in or relating to methods of treating damaged skin | |
SE8403487D0 (sv) | Farmaceutisk komposition | |
ATE140918T1 (de) | Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln | |
DE69103755D1 (de) | Wachstumshormonkristalle und verfahren zu deren herstellung. | |
EP0404283A3 (de) | 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel | |
ATE143601T1 (de) | Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose | |
DE3575725D1 (de) | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
DE3162614D1 (en) | Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same | |
ES8607916A1 (es) | Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida) | |
DE3850778D1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
ATE141160T1 (de) | Ein flurbiprofen enthaltendes akutarzneimittel und seine verwendung | |
DE69015910D1 (de) | Pharmazeutische Verwendung von Fettsäuren. | |
ATE135220T1 (de) | Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose | |
ATE121405T1 (de) | Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
DE59304087D1 (de) | Placentaextrakt und Verfahren zu seiner Herstellung | |
ATE82850T1 (de) | Verwendung von 2-pyrimidinyl-1-piperazinderivaten. | |
DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
DE68920022D1 (de) | Indolessigsäure-derivate, verfahren zur herstellung sowie arzneimittel, die diese als aktive mittel enthalten. | |
MX9703359A (es) | Acidos 2,2-dicloroalcancarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar resistencia a la insulina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |